Literature DB >> 24616209

The mechanism by which TATA-box polymorphisms associated with human hereditary diseases influence interactions with the TATA-binding protein.

Irina Drachkova1, Ludmila Savinkova, Tatyana Arshinova, Mikhail Ponomarenko, Sergey Peltek, Nikolay Kolchanov.   

Abstract

SNPs in ТАТА boxes are the cause of monogenic diseases, contribute to a large number of complex diseases, and have implications for human sensitivity to external and internal environmental signals. The aim of this work was to explore the kinetic characteristics of the formation of human ТВР complexes with ТАТА boxes, in which the SNPs are associated with β-thalassemias of diverse severity, immunosuppression, neurological disorders, and so on. It has for the first time been demonstrated, using an electrophoretic mobility shift assay, that TBP interacts with SNP-containing ТАТА boxes with a significant (8-36-fold) decrease in TBP/ТАТА association rate constant (ka ) as compared with that in healthy people, a smaller decrease in dissociation rate constant (kd ) and changes in the half-lives of TBP/ТАТА complexes. Carriers of the -24G allele (rs 1800202T>G) in the TATA box of the triosephosphate isomerase gene promoter, associated with neurological and muscular disorders, were observed to have a 36-fold decrease in TBP/TATA association rate constant that are consistent with TPI deficiency shown for patients who carry this defective allele. The kinetic characteristics of TBP/ТАТА complexes obtained suggest that, at a molecular level, hereditary diseases are largely caused by changes in TBP/ТАТА association rates and these changes have a bearing on disease severity.
© 2014 WILEY PERIODICALS, INC.

Entities:  

Keywords:  TBP; association rate; dissociation rate; hereditary disease; ТАТА box

Mesh:

Substances:

Year:  2014        PMID: 24616209     DOI: 10.1002/humu.22535

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Regulatory single nucleotide polymorphisms at the beginning of intron 2 of the human KRAS gene.

Authors:  Elena V Antontseva; Marina Yu Matveeva; Natalia P Bondar; Elena V Kashina; Elena Yu Leberfarb; Leonid O Bryzgalov; Polina A Gervas; Anastasia A Ponomareva; Nadezhda V Cherdyntseva; Yury L Orlov; Tatiana I Merkulova
Journal:  J Biosci       Date:  2015-12       Impact factor: 1.826

2.  Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Mikhail P Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Marina Yu Matveeva; Tatjana V Arshinova; Petr M Ponomarenko; Olga V Arkova; Natalia P Bondar; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2016-12-28       Impact factor: 3.969

3.  How to Use SNP_TATA_Comparator to Find a Significant Change in Gene Expression Caused by the Regulatory SNP of This Gene's Promoter via a Change in Affinity of the TATA-Binding Protein for This Promoter.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Olga Arkova; Petr Ponomarenko; Valentin Suslov; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

4.  Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters.

Authors:  Olga V Arkova; Mikhail P Ponomarenko; Dmitry A Rasskazov; Irina A Drachkova; Tatjana V Arshinova; Petr M Ponomarenko; Ludmila K Savinkova; Nikolay A Kolchanov
Journal:  BMC Genomics       Date:  2015-12-16       Impact factor: 3.969

5.  Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Irina Chadaeva; Dmitry A Rasskazov; Ekaterina Sharypova; Elena V Kashina; Irina Drachkova; Dmitry Zhechev; Mikhail P Ponomarenko; Ludmila K Savinkova; Nikolay Kolchanov
Journal:  Front Aging Neurosci       Date:  2017-07-20       Impact factor: 5.750

6.  Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters.

Authors:  Irina V Chadaeva; Petr M Ponomarenko; Dmitry A Rasskazov; Ekaterina B Sharypova; Elena V Kashina; Dmitry A Zhechev; Irina A Drachkova; Olga V Arkova; Ludmila K Savinkova; Mikhail P Ponomarenko; Nikolay A Kolchanov; Ludmila V Osadchuk; Alexandr V Osadchuk
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

7.  Candidate SNP Markers of Atherogenesis Significantly Shifting the Affinity of TATA-Binding Protein for Human Gene Promoters show stabilizing Natural Selection as a Sum of Neutral Drift Accelerating Atherogenesis and Directional Natural Selection Slowing It.

Authors:  Mikhail Ponomarenko; Dmitry Rasskazov; Irina Chadaeva; Ekaterina Sharypova; Irina Drachkova; Dmitry Oshchepkov; Petr Ponomarenko; Ludmila Savinkova; Evgeniya Oshchepkova; Maria Nazarenko; Nikolay Kolchanov
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

8.  Human Genes Encoding Transcription Factors and Chromatin-Modifying Proteins Have Low Levels of Promoter Polymorphism: A Study of 1000 Genomes Project Data.

Authors:  Elena V Ignatieva; Victor G Levitsky; Nikolay A Kolchanov
Journal:  Int J Genomics       Date:  2015-08-31       Impact factor: 2.326

9.  Real-Time Interaction between TBP and the TATA Box of the Human Triosephosphate Isomerase Gene Promoter in the Norm and Pathology.

Authors:  O V Arkova; N A Kuznetsov; O S Fedorova; N A Kolchanov; L K Savinkova
Journal:  Acta Naturae       Date:  2014-04       Impact factor: 1.845

10.  Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Mikhail P Ponomarenko; Olga Arkova; Dmitry Rasskazov; Petr Ponomarenko; Ludmila Savinkova; Nikolay Kolchanov
Journal:  Front Immunol       Date:  2016-04-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.